Platelet purinergic receptors.

[1]  G. Vilaire,et al.  Concurrent signaling from Gαq‐ and Gαi‐coupled pathways is essential for agonist‐induced αvβ3 activation on human platelets , 2003, Journal of thrombosis and haemostasis : JTH.

[2]  Jianguo Jin,et al.  Coordinated Signaling through Both G12/13 and Gi Pathways Is Sufficient to Activate GPIIb/IIIa in Human Platelets* , 2002, The Journal of Biological Chemistry.

[3]  S. Kunapuli,et al.  Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. , 2002, The Biochemical journal.

[4]  L. Brass,et al.  Signaling through Gi Family Members in Platelets , 2002, The Journal of Biological Chemistry.

[5]  K. Jacobson,et al.  Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist. , 2002, Molecular pharmacology.

[6]  B. Nieswandt,et al.  Costimulation of Gi- and G12/G13-mediated Signaling Pathways Induces Integrin αIIbβ3 Activation in Platelets* , 2002, The Journal of Biological Chemistry.

[7]  J. Vermylen,et al.  P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. , 2002, Blood.

[8]  M. Rolf,et al.  Effects of Enhanced P2X1 Receptor Ca2+ Influx on Functional Responses in Human Platelets , 2002, Thrombosis and Haemostasis.

[9]  L. Brass,et al.  Activation of Rap1B by Gi Family Members in Platelets* , 2002, The Journal of Biological Chemistry.

[10]  S. Goto,et al.  Functional Significance of Adenosine 5′-Diphosphate Receptor (P2Y12) in Platelet Activation Initiated by Binding of von Willebrand Factor to Platelet GP Ib&agr; Induced by Conditions of High Shear Rate , 2002, Circulation.

[11]  F. Ozdener,et al.  Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP. , 2002, Blood.

[12]  P. Nurden,et al.  Role of ADP Receptor P2Y12 in Platelet Adhesion and Thrombus Formation in Flowing Blood , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[13]  R. Evans,et al.  A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors , 2002, British journal of pharmacology.

[14]  J. Moake,et al.  Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. , 2001, Blood.

[15]  B. Nieswandt,et al.  The P2Y12 receptor induces platelet aggregation through weak activation of the αIIbβ3 integrin – a phosphoinositide 3‐kinase‐dependent mechanism , 2001 .

[16]  T. Saito,et al.  Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. , 2001, Molecular pharmacology.

[17]  E. Hirsch,et al.  Resistance to thromboembolism in PI3Kγ‐deficient mice , 2001 .

[18]  J. Vermylen,et al.  The ATP-Gated P2X1 Ion Channel Acts as a Positive Regulator of Platelet Responses to Collagen , 2001, Thrombosis and Haemostasis.

[19]  P. Conley,et al.  Impaired activation of murine platelets lacking Gαi2 , 2001 .

[20]  F. Monsma,et al.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. , 2001, The Journal of clinical investigation.

[21]  S. Kunapuli,et al.  The C6‐2B glioma cell P2YAC receptor is pharmacologically and molecularly identical to the platelet P2Y12 receptor , 2001, British journal of pharmacology.

[22]  J. Herbert,et al.  P2y(12), a new platelet ADP receptor, target of clopidogrel. , 2001, Biochemical and biophysical research communications.

[23]  F. Monsma,et al.  ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999* , 2001, The Journal of Biological Chemistry.

[24]  M. Freund,et al.  Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. , 2001, Circulation.

[25]  S. Kunapuli,et al.  Potentiation of Thromboxane A2-induced Platelet Secretion by Gi Signaling through the Phosphoinositide-3 Kinase Pathway , 2001, Thrombosis and Haemostasis.

[26]  C. Brearley,et al.  Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATP , 2001, Thrombosis and Haemostasis.

[27]  David Julius,et al.  Identification of the platelet ADP receptor targeted by antithrombotic drugs , 2001, Nature.

[28]  H. Koike,et al.  Antiplatelet action of R‐99224, an active metabolite of a novel thienopyridine‐type Gi‐linked P2T antagonist, CS‐747 , 2001, British journal of pharmacology.

[29]  S. Goto,et al.  Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation , 2001, Platelets.

[30]  J. Herbert,et al.  Identification and Biological Activity of the Active Metabolite of Clopidogrel , 2000, Thrombosis and Haemostasis.

[31]  A. Wetter,et al.  Molecular pharmacology of P2Y-receptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[32]  R. Evans,et al.  ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets , 2000, British journal of pharmacology.

[33]  W R Bell,et al.  Thrombotic thrombocytopenic purpura associated with clopidogrel. , 2000, The New England journal of medicine.

[34]  S. Kunapuli,et al.  The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets. , 2000, European journal of biochemistry.

[35]  J. Brown,et al.  Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors , 2000, Nature.

[36]  J P Cazenave,et al.  Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. , 1999, The Journal of clinical investigation.

[37]  Beverly H. Koller,et al.  Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice , 1999, Nature Medicine.

[38]  J. Kimura,et al.  No requirement of P2X1 purinoceptors for platelet aggregation. , 1999, European journal of pharmacology.

[39]  C. Gachet,et al.  Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. , 1999, Biochemical and biophysical research communications.

[40]  S. Kunapuli,et al.  Multiple P2 receptor subtypes on platelets: a new interpretation of their function. , 1998, Trends in pharmacological sciences.

[41]  J. Cazenave,et al.  The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. , 1998, Blood.

[42]  U. Walter,et al.  Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. , 1998, European journal of pharmacology.

[43]  M. J. Robertson,et al.  P2Y1‐receptors in human platelets which are pharmacologically distinct from P2YADP‐receptors , 1998, British journal of pharmacology.

[44]  S. Moro,et al.  Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. , 1998, Journal of medicinal chemistry.

[45]  S. Kunapuli,et al.  Molecular Basis for ADP-induced Platelet Activation , 1998, The Journal of Biological Chemistry.

[46]  B. Ashby,et al.  Molecular Basis for ADP-induced Platelet Activation , 1998, The Journal of Biological Chemistry.

[47]  D. Mills,et al.  ADP Receptors on Platelets , 1996, Thrombosis and Haemostasis.

[48]  T. K. Harden,et al.  Identification of competitive antagonists of the P2Y1 receptor. , 1996, Molecular pharmacology.

[49]  M. J. Robertson,et al.  A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. , 1995, Trends in pharmacological sciences.

[50]  S. Kunapuli,et al.  Adenosine diphosphate (ADP)–induced thromboxane A2generation in human platelets requires coordinated signaling through integrin αIIbβ3 and ADP receptors , 2002 .

[51]  J. Bennett.  Novel platelet inhibitors. , 2001, Annual review of medicine.

[52]  P. Conley,et al.  Evidence for Two Distinct G-protein-coupled ADP Receptors Mediating Platelet Activation , 1999, Thrombosis and Haemostasis.

[53]  J. Cazenave,et al.  Purinergic receptors on blood platelets. , 1996, Platelets.